GlassScriptPhysician profile
Todd J Frush
NPI 1427264910
$75,544.75
in general payments reported to CMS, 2019-2025
13 companies · $7,785 in 2025
The $7,785 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,382 · 2021: $9,722 · 2022: $16K · 2023: $7,367 · 2024: $19K · 2025: $7,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $12K · Food and Beverage: $1,496 · Gift: $25.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,600.00 |
| Travel and Lodging | $12,416.33 |
| Food and Beverage | $1,496.07 |
| Gift | $25.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bodycad USA Corp | $24,408.50 | 2021-2025 | Fine Osteotomy |
| Arthrex, INC. | $23,029.42 | 2019-2023 | |
| Medacta USA, INC. | $19,255.78 | 2023-2025 | Mecta, Gmk Sphere, Moto Pfj |
| Pinnacle, INC | $6,206.36 | 2019-2025 | |
| Stryker Corporation | $1,863.99 | 2019-2024 | Mako, Insignia |
| Miach Orthopaedics, INC. | $214.11 | 2025 | |
| Depuy Synthes Sales INC. | $207.47 | 2019-2024 | Va-Lcp |
| Microport Orthopedics INC | $127.61 | 2020 | |
| Smith+Nephew, INC. | $103.38 | 2023-2024 | Real Intelligence, Acufex Trunav, Acufex Director |
| Vericel Corporation | $66.45 | 2022-2025 | Maci |
| Heron Therapeutics, INC. | $22.10 | 2024 | Zynrelef |
| Medtronic, INC. | $21.38 | 2024 | Inceptiv |
| Ermi LLC | $18.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Frush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.